Retrospective pharmacogenetic study in a cohort of pediatric tuberous sclerosis complex patients using everolimus
出版年份 2023 全文链接
标题
Retrospective pharmacogenetic study in a cohort of pediatric tuberous sclerosis complex patients using everolimus
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 24, Issue 15, Pages 797-808
出版商
Future Medicine Ltd
发表日期
2023-10-23
DOI
10.2217/pgs-2023-0140
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Perfect match: mTOR inhibitors and tuberous sclerosis complex
- (2022) Cong Luo et al. Orphanet Journal of Rare Diseases
- Evaluation of Pharmacogenetics of Drug-Metabolizing Enzymes and Drug Efflux Transporter in Renal Transplants Receiving Immunosuppressants
- (2022) Kannan Sridharan et al. Journal of Personalized Medicine
- Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
- (2022) Mercè Brunet et al. Pharmaceutics
- Factors associated with autism spectrum disorder in children with tuberous sclerosis complex: a systematic review and meta‐analysis
- (2021) Rebecca A Mitchell et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Everolimus for cardiac rhabdomyomas in children with tuberous sclerosis. The ORACLE study protocol (everOlimus for caRdiac rhAbdomyomas in tuberous sCLErosis): a randomised, multicentre, placebo-controlled, double-blind phase II trial
- (2020) Erica V. Stelmaszewski et al. CARDIOLOGY IN THE YOUNG
- Significance of ethnic factors in immunosuppressive therapy management after organ transplantation
- (2020) Takaaki Yamada et al. THERAPEUTIC DRUG MONITORING
- Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial
- (2020) Katarzyna Kotulska et al. ANNALS OF NEUROLOGY
- Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer
- (2017) Tomas Pascual et al. PLoS One
- Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
- (2016) Jacqueline A French et al. LANCET
- CYP3A4 intronic SNP rs35599367 (CYP3A4*22) alters RNA splicing
- (2016) Danxin Wang et al. Pharmacogenetics and Genomics
- Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in “Omics” Medicine
- (2015) Gianluigi Zaza et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex
- (2015) Jeffrey P. MacKeigan et al. NEURO-ONCOLOGY
- Effects of the CYP3A4*1B Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Adult Renal Transplant Recipients: A Meta-Analysis
- (2015) Wei-Long Shi et al. PLoS One
- The impact of genetic polymorphisms, diltiazem, and demographic variables on everolimus trough concentrations in lung transplant recipients
- (2014) Kelly E. Schoeppler et al. CLINICAL TRANSPLANTATION
- Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patient
- (2014) C. Lecefel et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Genetic Association Analysis of ATP Binding Cassette Protein Family Reveals a Novel Association of ABCB1 Genetic Variants with Epilepsy Risk, but Not with Drug-Resistance
- (2014) Shabeesh Balan et al. PLoS One
- The PXR rs7643645 Polymorphism Is Associated with the Risk of Higher Prostate-Specific Antigen Levels in Prostate Cancer Patients
- (2014) Octavio D. Reyes-Hernández et al. PLoS One
- Screening of Genetic Polymorphisms ofCYP3A4andCYP3A5Genes
- (2013) Jin Sol Lee et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
- (2013) John J Bissler et al. LANCET
- Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
- (2013) Darcy A. Krueger et al. PEDIATRIC NEUROLOGY
- Impact of POR*28 on the Pharmacokinetics of Tacrolimus and Cyclosporine a in Renal Transplant Patients
- (2013) Laure Elens et al. THERAPEUTIC DRUG MONITORING
- Frequency and prognostic significant of CYP3A4-A-290G polymorphism in acute myeloid leukemia
- (2013) Gamal T. Ali et al. Journal of Advanced Research
- Population Pharmacokinetics and Pharmacogenetics of Everolimus in Renal Transplant Patients
- (2012) Dirk Jan A.R. Moes et al. CLINICAL PHARMACOKINETICS
- Population Pharmacokinetics of Everolimus in Cardiac Recipients
- (2012) Florian Lemaitre et al. THERAPEUTIC DRUG MONITORING
- CYP2B6SNPs are associated with methadone dose required for effective treatment of opioid addiction
- (2011) Orna Levran et al. ADDICTION BIOLOGY
- Sirolimus and everolimus intestinal absorption and interaction with calcineurin inhibitors: a differential effect between cyclosporine and tacrolimus
- (2011) Fabien Lamoureux et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- CYP3A5 Genotype Does Not Influence Everolimus In Vitro Metabolism and Clinical Pharmacokinetics in Renal Transplant Recipients
- (2011) Nicolas Picard et al. TRANSPLANTATION
- Everolimus
- (2011) Monique P. Curran PEDIATRIC DRUGS
- Sirolimus for calcineurin inhibitors in organ transplantation: contra
- (2010) Paolo Cravedi et al. KIDNEY INTERNATIONAL
- A map of human genome variation from population-scale sequencing
- (2010) Richard M. Durbin et al. NATURE
- The role of CYP3A5 genotypes in dose requirements of tacrolimus and everolimus after heart transplantation
- (2009) Daniela Kniepeiss et al. CLINICAL TRANSPLANTATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started